Physician profile
Cynthia B Anders
NPI 1972502714
$2,122.32
in general payments reported to CMS, 2019-2025
26 companies · $62.82 in 2025
The $62.82 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $495 · 2022: $1,082 · 2023: $432 · 2024: $50.60 · 2025: $62.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229 · Travel and Lodging: $216 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.46 |
| Travel and Lodging | $215.98 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $385.32 | 2023 | Da Vinci Surgical System, Davinci Xi |
| Janssen Biotech, INC. | $315.30 | 2021-2022 | |
| Myovant Sciences INC. | $290.73 | 2021-2022 | |
| Abbvie INC. | $187.95 | 2021-2024 | |
| Tolmar Pharmaceuticals, INC. | $173.17 | 2022 | |
| Pfizer INC. | $103.12 | 2021-2022 | |
| Astellas Pharma US INC | $99.82 | 2021-2022 | |
| Boston Scientific Corporation | $66.77 | 2021 | |
| Coloplast Corp | $63.09 | 2022-2023 | Titan |
| Bayer Healthcare Pharmaceuticals INC. | $56.91 | 2022 | |
| Rochester Medical Corporation | $44.01 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $42.52 | 2021-2022 | |
| Lsi Solutions INC | $41.56 | 2025 | Fornisee |
| Clarus Therapeutics INC. | $37.37 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.50 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $28.26 | 2022 | |
| Abiomed | $21.26 | 2025 | |
| Olympus America INC. | $20.50 | 2022 | |
| Blue Earth Diagnostics | $18.30 | 2021 | |
| Ambu INC. | $17.95 | 2021 | |
| Urovant Sciences INC | $17.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.48 | 2024 | Exparel |
| Laborie Medical Technologies Corp. | $13.69 | 2022 | |
| Allergan, INC. | $13.54 | 2022 | |
| Dentsply Ih INC. | $13.16 | 2021 | |
| Travere Therapeutics, INC. | $2.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.